Virios Therapeutics

About Virios Therapeutics

Virios Therapeutics, now known as Dogwood Therapeutics, Inc., is focused on exploring a new treatment paradigm for Fibromyalgia.

Specialties

Fibromyalgia treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 1700000 MR: - FA: $1.7 million FAN: 1700000	D: 2024-05-22 FD: 2024-05-22	-
2	RT: Public Offering T: - FT: Public Offering	A: 1700000 MR: - FA: 1.7 million FAN: 1700000	D: 2024-05-19 FD: 2024-05-19	-

Public Offering Latest

2024-05-22

$1.7M

Public Offering 2024-05-19

$1.7M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Virios Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised